CNS Pharmaceuticals, Inc. Quarterly Depreciation in USD from Q1 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
CNS Pharmaceuticals, Inc. quarterly/annual Depreciation history and growth rate from Q1 2019 to Q1 2024.
  • CNS Pharmaceuticals, Inc. Depreciation for the quarter ending March 31, 2024 was $818.000, a 36% decline year-over-year.
  • CNS Pharmaceuticals, Inc. annual Depreciation for 2023 was $4.13K, a 64.8% decline from 2022.
  • CNS Pharmaceuticals, Inc. annual Depreciation for 2022 was $11.8K, a 10.1% decline from 2021.
  • CNS Pharmaceuticals, Inc. annual Depreciation for 2021 was $13.1K, a 17.8% increase from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $818 -$461 -36% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q1 2023 $1.28K -$2.1K -62.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q1 2022 $3.38K +$377 +12.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q1 2021 $3K +$1.08K +56.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q1 2020 $1.92K +$1.92K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q1 2019 $0 Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.